WUHAN, China, March 25, 2021 /PRNewswire/ -- Chime Biologics, a China-based, world-class CDMO company, announced today that it has secured a total commitment of US$190 million investment from institutional investors, and over $100 million investment has already been closed today. This...
from PR Newswire: https://ift.tt/2Pbvtmm
No comments:
Post a Comment